Cargando…
Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
The apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for Alzheimer’s disease (AD). The influence of apoE on amyloid β (Aβ) accumulation may be the major mechanism by which apoE affects AD. ApoE interacts with Aβ and facilitates Aβ fibrillogenesis in vitro. In addition, apoE is...
Autores principales: | Kim, Jungsu, Eltorai, Adam E.M., Jiang, Hong, Liao, Fan, Verghese, Philip B., Kim, Jaekwang, Stewart, Floy R., Basak, Jacob M., Holtzman, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501350/ https://www.ncbi.nlm.nih.gov/pubmed/23129750 http://dx.doi.org/10.1084/jem.20121274 |
Ejemplares similares
-
ApoE facilitates the microglial response to amyloid plaque pathology
por: Ulrich, Jason D., et al.
Publicado: (2018) -
Apolipoprotein E in Synaptic Plasticity and Alzheimer’s Disease: Potential Cellular and Molecular Mechanisms
por: Kim, Jaekwang, et al.
Publicado: (2014) -
APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice
por: Pankiewicz, Joanna E, et al.
Publicado: (2017) -
Neuronal activity regulates extracellular tau in vivo
por: Yamada, Kaoru, et al.
Publicado: (2014) -
Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease
por: Roh, Jee Hoon, et al.
Publicado: (2014)